Johnson & Johnson’s single-dose COVID-19 vaccine. (CNN) There is some good news on Johnson & Johnson’s coronavirus vaccine. Early results from a Phase 1/2a clinical trial show it was well tolerated…
https://www.cnn.com/2020/09/25/us/johnson-and-johnson-vaccine-strong-immune-response/index.html

